Viewing Study NCT07115095


Ignite Creation Date: 2025-12-24 @ 2:12 PM
Ignite Modification Date: 2026-01-02 @ 7:42 AM
Study NCT ID: NCT07115095
Status: COMPLETED
Last Update Posted: 2025-08-11
First Post: 2025-07-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Tumor Markers for Efficacy of Dual-Target Therapy in HER2+ Breast Cancer
Sponsor: Nanlin Li
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module